CYCLOPENTOLATE HYDROCHLORIDE

CYCLOPENTOLATE HYDROCHLORIDE was reported 659 times

CYCLOPENTOLATE HYDROCHLORIDE is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 GASTRIC RESIDUAL INCREASED 8 0.2759
1 GRAM STAIN 1 0.2000
2 RADIOTHERAPY TO LIVER 1 0.1111
3 DEEP ANTERIOR CHAMBER OF THE EYE 1 0.1000
4 PUPILLARY BLOCK 3 0.0938
5 VITREOUS ABSCESS 1 0.0909
6 IRIS VASCULAR DISORDER 1 0.0667
7 SYMPATHETIC OPHTHALMIA 1 0.0625
8 AQUEOUS FIBRIN 3 0.0588
9 FOVEAL REFLEX ABNORMAL 1 0.0588
10 CORNEAL EPITHELIUM DISORDER 2 0.0571
11 LENTICULAR PIGMENTATION 1 0.0417
12 TOXIC ANTERIOR SEGMENT SYNDROME 33 0.0302
13 VERBIGERATION 3 0.0294
14 CORNEAL EPITHELIUM DEFECT 16 0.0275
15 ANTERIOR CHAMBER CELL 17 0.0238
16 KERATOPLASTY 1 0.0238
17 FIBRIN 1 0.0233
18 VOGT-KOYANAGI-HARADA DISEASE 5 0.0227
19 UTERINE CERVICAL SQUAMOUS METAPLASIA 1 0.0222
20 PH BODY FLUID ABNORMAL 3 0.0216
21 CILIARY BODY DISORDER 2 0.0202
22 CONJUNCTIVAL BLEB 1 0.0185
23 FEEDING INTOLERANCE 8 0.0177
24 PUNCTATE KERATITIS 16 0.0174
25 KERATOPATHY 26 0.0164
26 ANTERIOR CHAMBER FIBRIN 2 0.0155
27 MITOCHONDRIAL MYOPATHY ACQUIRED 1 0.0154
28 WRONG PRODUCT PROCURED 1 0.0152
29 AUTOIMMUNE UVEITIS 1 0.0152
30 CORNEAL ENDOTHELIAL CELL LOSS 1 0.0147
31 EYE INFECTION INTRAOCULAR 1 0.0128
32 VITREOUS DEGENERATION 2 0.0122
33 CORNEAL DEPOSITS 9 0.0121
34 POSTERIOR CAPSULE OPACIFICATION 4 0.0117
35 PSEUDOPHAKIA 1 0.0115
36 CUTIS LAXA 3 0.0110
37 ARTERIOSCLEROTIC RETINOPATHY 1 0.0110
38 IRIS TRANSILLUMINATION DEFECT 2 0.0107
39 PIGMENT DISPERSION SYNDROME 1 0.0105
40 VIRAL UVEITIS 1 0.0103
41 ERYTHROPSIA 1 0.0102
42 CORNEAL OEDEMA 22 0.0098
43 SYSTEMIC TOXICITY 2 0.0098
44 TRIGGER POINTS 1 0.0095
45 CORNEAL ABSCESS 1 0.0093
46 DRUG EFFECT PROLONGED 5 0.0091
47 CORNEAL TOXICITY 1 0.0090
48 ANGIOGRAM ABNORMAL 1 0.0089
49 PERSISTENT CORNEAL EPITHELIAL DEFECT 1 0.0085
50 HYPOPYON 7 0.0085
51 DIVERTICULUM OESOPHAGEAL 1 0.0083
52 FIXED DRUG ERUPTION 1 0.0082
53 SENILE OSTEOPOROSIS 1 0.0081
54 DRUG LABEL CONFUSION 2 0.0080
55 TRANSIENT APHASIA 1 0.0076
56 INSTILLATION SITE DISCOMFORT 1 0.0075
57 HYPOTONY OF EYE 3 0.0071
58 HLA-B*27 POSITIVE 1 0.0071
59 SUPRAVENTRICULAR TACHYARRHYTHMIA 1 0.0071
60 CORNEAL ABRASION 9 0.0066
61 AORTIC VALVE THICKENING 1 0.0062
62 RETINAL DRUSEN 1 0.0061
63 CATARACT NUCLEAR 4 0.0060
64 PAPILLITIS 1 0.0060
65 GLARE 3 0.0058
66 OPHTHALMOLOGICAL EXAMINATION ABNORMAL 1 0.0056
67 FLAT ANTERIOR CHAMBER OF EYE 1 0.0056
68 ACANTHOSIS NIGRICANS 1 0.0054
69 ACANTHAMOEBA INFECTION 1 0.0053
70 CERVIX HAEMORRHAGE UTERINE 1 0.0052
71 CORNEAL OPACITY 7 0.0051
72 ANTERIOR CHAMBER INFLAMMATION 3 0.0050
73 LENS DISLOCATION 1 0.0048
74 CORNEAL GRAFT REJECTION 1 0.0048
75 PUPIL FIXED 8 0.0046
76 GRIP STRENGTH 1 0.0044
77 RETINAL SCAR 2 0.0043
78 LACRIMATION DECREASED 2 0.0042
79 CORNEAL SCAR 2 0.0040
80 CORNEAL THINNING 1 0.0039
81 GINGIVAL EROSION 1 0.0039
82 IRIDOCYCLITIS 12 0.0038
83 GASTRIC BANDING 1 0.0038
84 ANTICHOLINERGIC SYNDROME 6 0.0038
85 BACTERIAL ENDOPHTHALMITIS 1 0.0038
86 BLOOD CHOLINESTERASE DECREASED 1 0.0036
87 CHOROIDAL DETACHMENT 2 0.0036
88 EPIRETINAL MEMBRANE 1 0.0036
89 CHEMICAL BURNS OF EYE 1 0.0036
90 LENS DISORDER 1 0.0035
91 CATARACT SUBCAPSULAR 2 0.0033
92 EYE INFECTION VIRAL 1 0.0031
93 PARAKERATOSIS 1 0.0031
94 ALOPECIA TOTALIS 1 0.0030
95 SOFT TISSUE INFLAMMATION 1 0.0030
96 PERIORBITAL IRRITATION 1 0.0029
97 CONJUNCTIVAL OEDEMA 3 0.0029
98 RETINAL PIGMENT EPITHELIAL TEAR 2 0.0029
99 RADICULAR PAIN 1 0.0029
100 INFECTED DERMAL CYST 1 0.0028
101 PRODUCT COMPOUNDING QUALITY ISSUE 1 0.0027
102 ACCOMMODATION DISORDER 2 0.0027
103 VITRITIS 5 0.0027
104 CHOROIDITIS 1 0.0027
105 IRITIS 8 0.0026
106 VITAMIN K DEFICIENCY 1 0.0025
107 LYMPHOCYTE PERCENTAGE INCREASED 1 0.0025
108 TONGUE ERYTHEMA 2 0.0024
109 ENDOPHTHALMITIS 14 0.0023
110 ABDOMINAL SEPSIS 2 0.0023
111 DETACHMENT OF RETINAL PIGMENT EPITHELIUM 2 0.0022
112 THERAPEUTIC PRODUCT EFFECT PROLONGED 1 0.0022
113 EXTRAOCULAR MUSCLE PARESIS 1 0.0022
114 SUDDEN ONSET OF SLEEP 3 0.0022
115 BRAIN STEM HAEMORRHAGE 2 0.0021
116 MYDRIASIS 27 0.0021
117 ORAL CAVITY FISTULA 1 0.0020
118 LOWER RESPIRATORY TRACT INFECTION VIRAL 1 0.0020
119 HERPES ZOSTER OTICUS 1 0.0020
120 IRIS ADHESIONS 1 0.0019
121 CHOLANGITIS SCLEROSING 4 0.0019
122 HYPHAEMA 1 0.0019
123 NO REACTION ON PREVIOUS EXPOSURE TO DRUG 1 0.0019
124 NAIL RIDGING 1 0.0019
125 INTRAOCULAR PRESSURE DECREASED 1 0.0019
126 INSTILLATION SITE ERYTHEMA 1 0.0019
127 ANAL STENOSIS 1 0.0019
128 IRIS DISORDER 1 0.0019
129 EOSINOPHIL PERCENTAGE INCREASED 1 0.0018
130 RETINAL DETACHMENT 17 0.0018
131 UVEITIS 25 0.0018
132 GROIN INFECTION 1 0.0018
133 VISUAL ACUITY TESTS ABNORMAL 1 0.0018
134 APNOEIC ATTACK 1 0.0018
135 THYROXINE FREE DECREASED 1 0.0018
136 ADMINISTRATION SITE PAIN 2 0.0017
137 CELLULITIS ORBITAL 1 0.0017
138 GRAFT COMPLICATION 1 0.0017
139 URETHRAL PAIN 1 0.0017
140 VITRECTOMY 1 0.0017
141 STAPHYLOCOCCAL SKIN INFECTION 2 0.0016
142 LYMPH NODE PAIN 3 0.0016
143 SUSPECTED TRANSMISSION OF AN INFECTIOUS AGENT VIA PRODUCT 2 0.0016
144 CORTISOL INCREASED 1 0.0016
145 FOREIGN BODY SENSATION IN EYES 10 0.0016
146 BLOOD CORTISOL DECREASED 1 0.0016
147 APNOEA 12 0.0015
148 PHOTOPHOBIA 28 0.0015
149 SURGICAL PROCEDURE REPEATED 1 0.0015
150 CUSHING'S SYNDROME 1 0.0014
151 INTRAOCULAR PRESSURE TEST ABNORMAL 1 0.0014
152 CORNEAL DISORDER 3 0.0014
153 CYCLIC VOMITING SYNDROME 1 0.0014
154 CENTRAL OBESITY 1 0.0014
155 RETINAL VASCULAR OCCLUSION 1 0.0014
156 CORNEAL TRANSPLANT 1 0.0013
157 SUPERINFECTION BACTERIAL 1 0.0013
158 INTRAOCULAR PRESSURE INCREASED 16 0.0013
159 EXCESSIVE GRANULATION TISSUE 1 0.0012
160 INTERVERTEBRAL DISC SPACE NARROWING 1 0.0012
161 PRODUCT PACKAGING CONFUSION 3 0.0012
162 RETINAL TEAR 3 0.0012
163 CARDIAC STRESS TEST ABNORMAL 1 0.0012
164 SEROUS RETINAL DETACHMENT 1 0.0012
165 ADRENAL SUPPRESSION 1 0.0012
166 VITREOUS OPACITIES 1 0.0012
167 PERIORBITAL PAIN 1 0.0012
168 NON-INFECTIOUS ENDOPHTHALMITIS 1 0.0012
169 INCORRECT PRODUCT FORMULATION ADMINISTERED 1 0.0011
170 EYE PAIN 63 0.0011
171 ANAESTHETIC COMPLICATION NEUROLOGICAL 1 0.0011
172 COLOUR BLINDNESS 1 0.0011
173 CEREBRAL THROMBOSIS 3 0.0011
174 FOREIGN BODY IN EYE 1 0.0010
175 OCULAR HYPERTENSION 2 0.0010
176 KERATITIS 3 0.0010
177 AUTISM 1 0.0010
178 EYELID PAIN 2 0.0010
179 CYTOGENETIC ANALYSIS ABNORMAL 1 0.0010
180 BURNS THIRD DEGREE 1 0.0009
181 GALLBLADDER ENLARGEMENT 1 0.0009
182 VITREOUS DETACHMENT 2 0.0009
183 ACINETOBACTER INFECTION 1 0.0009
184 OCULAR TOXICITY 1 0.0009
185 DRY AGE-RELATED MACULAR DEGENERATION 1 0.0009
186 BACTERIAL TEST POSITIVE 2 0.0009
187 HYPERSENSITIVITY PNEUMONITIS 1 0.0009
188 READING DISORDER 2 0.0009
189 EYE OPERATION 4 0.0009
190 OSTEOCHONDROSIS 1 0.0009
191 INSTILLATION SITE IRRITATION 1 0.0008
192 RETINAL VASCULITIS 1 0.0008
193 EYE INFLAMMATION 8 0.0008
194 PROSTATIC OPERATION 1 0.0008
195 STERNAL FRACTURE 1 0.0008
196 HYPERAESTHESIA TEETH 1 0.0008
197 RETINAL ARTERY OCCLUSION 2 0.0008
198 OSTEOPENIA 12 0.0008
199 BLOOD CREATINE PHOSPHOKINASE MB INCREASED 1 0.0008
200 EJECTION FRACTION DECREASED 12 0.0008
201 RETINAL DEGENERATION 1 0.0008
202 ENCEPHALITIS AUTOIMMUNE 1 0.0008
203 ABNORMAL SLEEP-RELATED EVENT 1 0.0008
204 IMPLANTABLE DEFIBRILLATOR INSERTION 1 0.0008
205 OCULAR DISCOMFORT 8 0.0007
206 MYELITIS TRANSVERSE 1 0.0007
207 PRECANCEROUS CELLS PRESENT 1 0.0007
208 NAIL INFECTION 1 0.0007
209 VISUAL ACUITY REDUCED 23 0.0007
210 SEBORRHOEIC KERATOSIS 1 0.0007
211 GLAUCOMA 13 0.0007
212 OCULAR HYPERAEMIA 32 0.0007
213 INTERCEPTED DRUG DISPENSING ERROR 1 0.0007
214 EPICONDYLITIS 1 0.0007
215 ADHESION 1 0.0007
216 PARAINFLUENZAE VIRUS INFECTION 1 0.0007
217 GRAND MAL CONVULSION 6 0.0006
218 EYE ALLERGY 1 0.0006
219 EYE DISORDER 21 0.0006
220 HAEMORRHOIDS 12 0.0006
221 VITREOUS FLOATERS 6 0.0006
222 BRADYARRHYTHMIA 1 0.0006
223 ILLUSION 1 0.0006
224 VENA CAVA THROMBOSIS 1 0.0006
225 THERAPEUTIC AGENT TOXICITY 2 0.0006
226 HYPOPNOEA 2 0.0006
227 PRESYNCOPE 14 0.0006
228 APLASTIC ANAEMIA 3 0.0006
229 LACRIMATION INCREASED 17 0.0006
230 RETINAL HAEMORRHAGE 4 0.0006
231 CONJUNCTIVAL HYPERAEMIA 2 0.0006
232 OPHTHALMIC HERPES ZOSTER 1 0.0006
233 METAMORPHOPSIA 1 0.0005
234 DISORGANISED SPEECH 1 0.0005
235 PUPILLARY REFLEX IMPAIRED 1 0.0005
236 CONJUNCTIVITIS 10 0.0005
237 EYE IRRITATION 31 0.0005
238 CYSTOID MACULAR OEDEMA 1 0.0005
239 GUN SHOT WOUND 1 0.0005
240 TONGUE OEDEMA 2 0.0005
241 RETINAL OEDEMA 1 0.0005
242 HYPOREFLEXIA 1 0.0005
243 CATARACT OPERATION 3 0.0005
244 LIPIDS INCREASED 1 0.0005
245 DEVICE DEPOSIT ISSUE 1 0.0005
246 ABNORMAL SENSATION IN EYE 2 0.0005
247 FACIAL PALSY 1 0.0005
248 FEAR OF DEATH 1 0.0004
249 ISCHAEMIA 2 0.0004
250 HAEMANGIOMA 1 0.0004
251 NEPHROGENIC ANAEMIA 2 0.0004
252 ATAXIA 5 0.0004
253 PRODUCT SUPPLY ISSUE 3 0.0004
254 URINARY HESITATION 1 0.0004
255 POST PROCEDURAL COMPLICATION 8 0.0004
256 STARING 1 0.0004
257 RASH VESICULAR 2 0.0004
258 SLOW SPEECH 1 0.0004
259 EXPIRED DRUG ADMINISTERED 2 0.0004
260 HYPERPARATHYROIDISM SECONDARY 1 0.0004
261 PLATELET DISORDER 1 0.0004
262 PERIPHERAL VASCULAR DISORDER 2 0.0004
263 BLOOD CHLORIDE DECREASED 1 0.0004
264 PERIORBITAL OEDEMA 2 0.0004
265 PERSONALITY DISORDER 1 0.0004
266 RADICULOPATHY 1 0.0004
267 BLOOD POTASSIUM ABNORMAL 1 0.0004
268 ULCERATIVE KERATITIS 1 0.0004
269 COORDINATION ABNORMAL 5 0.0004
270 MACULAR OEDEMA 2 0.0004
271 ENDOTRACHEAL INTUBATION 1 0.0004
272 EYE INFECTION 4 0.0004
273 CIRCULATORY COLLAPSE 6 0.0004
274 NEUROLOGICAL SYMPTOM 2 0.0003
275 FIBULA FRACTURE 1 0.0003
276 EYELID MARGIN CRUSTING 1 0.0003
277 HYPERVENTILATION 2 0.0003
278 BLINDNESS 14 0.0003
279 LUMBAR SPINAL STENOSIS 1 0.0003
280 STRABISMUS 1 0.0003
281 GROWTH RETARDATION 1 0.0003
282 REBOUND ACID HYPERSECRETION 1 0.0003
283 PORTAL HYPERTENSION 1 0.0003
284 VISION BLURRED 44 0.0003
285 DRUG EFFECT INCREASED 1 0.0003
286 BLADDER PAIN 1 0.0003
287 CUSHINGOID 1 0.0003
288 INCOHERENT 2 0.0003
289 HYPOVENTILATION 1 0.0003
290 ASPERGILLUS INFECTION 2 0.0003
291 INFUSION SITE HAEMORRHAGE 1 0.0003
292 LISTLESS 1 0.0003
293 NEPHRITIS 1 0.0003
294 WOUND DEHISCENCE 1 0.0003
295 HEPATIC CYST 1 0.0003
296 INFLAMMATION 15 0.0003
297 LARGE INTESTINE POLYP 2 0.0003
298 EYE DISCHARGE 3 0.0003
299 HALLUCINATION, VISUAL 6 0.0003
300 VISUAL IMPAIRMENT 35 0.0003
301 PRODUCT CONTAMINATION 1 0.0003
302 RECTAL HAEMORRHAGE 12 0.0003
303 PANIC REACTION 2 0.0003
304 BLINDNESS TRANSIENT 2 0.0003
305 CATARACT 16 0.0003
306 HYPERACUSIS 1 0.0003
307 SNORING 1 0.0003
308 PRODUCT STORAGE ISSUE 1 0.0003
309 CYANOSIS 4 0.0003
310 DISORIENTATION 10 0.0003
311 MACULAR DEGENERATION 3 0.0003
312 CEREBRAL ATROPHY 1 0.0003
313 AZOTAEMIA 1 0.0003
314 OBSTRUCTION 1 0.0003
315 BLEPHARITIS 1 0.0002
316 INTRACRANIAL ANEURYSM 1 0.0002
317 PRODUCT ADMINISTRATION ERROR 5 0.0002
318 PLEURAL EFFUSION 15 0.0002
319 SPINAL STENOSIS 1 0.0002
320 THERAPEUTIC RESPONSE UNEXPECTED WITH DRUG SUBSTITUTION 1 0.0002
321 ACCIDENTAL EXPOSURE 1 0.0002
322 HYPERPYREXIA 1 0.0002
323 UTERINE HAEMORRHAGE 1 0.0002
324 HEPATIC PAIN 1 0.0002
325 HEPATIC LESION 1 0.0002
326 RESPIRATORY SYNCYTIAL VIRUS INFECTION 2 0.0002
327 DYSPHEMIA 1 0.0002
328 ONYCHOMYCOSIS 1 0.0002
329 CYTOMEGALOVIRUS INFECTION REACTIVATION 1 0.0002
330 PHYSICAL DISABILITY 1 0.0002
331 CATHETERISATION CARDIAC 1 0.0002
332 EYE HAEMORRHAGE 3 0.0002
333 FACIAL PAIN 2 0.0002
334 MALIGNANT MELANOMA 3 0.0002
335 DRUG TOXICITY 3 0.0002
336 BLOOD PRESSURE DIASTOLIC INCREASED 1 0.0002
337 SYNOVIAL CYST 1 0.0002
338 INTERCEPTED MEDICATION ERROR 1 0.0002
339 PERSONALITY CHANGE 2 0.0002
340 EYE SWELLING 8 0.0002
341 NEPHROPATHY 2 0.0002
342 BLINDNESS UNILATERAL 3 0.0002
343 SPINAL COLUMN STENOSIS 1 0.0002
344 SUPRAVENTRICULAR TACHYCARDIA 2 0.0002
345 EYE PRURITUS 7 0.0002
346 ATELECTASIS 2 0.0002
347 VENOOCCLUSIVE LIVER DISEASE 1 0.0002
348 HYPERNATRAEMIA 1 0.0002
349 FLUID INTAKE REDUCED 1 0.0002
350 PATHOLOGICAL FRACTURE 1 0.0002
351 DRUG DELIVERY SYSTEM MALFUNCTION 1 0.0002
352 CEREBRAL ISCHAEMIA 1 0.0002
353 FAILURE TO THRIVE 1 0.0002
354 VENTRICULAR EXTRASYSTOLES 2 0.0002
355 PARTIAL SEIZURES 1 0.0002
356 CATATONIA 1 0.0002
357 RENAL PAIN 2 0.0002
358 OVERWEIGHT 1 0.0002
359 PRODUCT RESIDUE PRESENT 1 0.0002
360 ERYTHEMA OF EYELID 1 0.0002
361 TIC 1 0.0002
362 ASTHENOPIA 1 0.0002
363 TRANSAMINASES INCREASED 4 0.0002
364 TOOTH DISORDER 4 0.0002
365 OBSTRUCTIVE AIRWAYS DISORDER 2 0.0002
366 EXERCISE TOLERANCE DECREASED 1 0.0002
367 EYELID OEDEMA 2 0.0002
368 PRODUCT LABEL CONFUSION 1 0.0002
369 DEVICE USE ISSUE 3 0.0002
370 URINE ODOUR ABNORMAL 1 0.0002
371 HYPERCHLORHYDRIA 1 0.0002
372 BRADYCARDIA 9 0.0002
373 DECREASED INTEREST 1 0.0002
374 MYOCLONUS 2 0.0002
375 SYMPTOM RECURRENCE 1 0.0002
376 BLOOD PRESSURE FLUCTUATION 4 0.0002
377 NO THERAPEUTIC RESPONSE 2 0.0002
378 RESTLESSNESS 6 0.0002
379 MUSCLE SPASTICITY 2 0.0002
380 DRUG ABUSER 1 0.0002
381 GENERALISED OEDEMA 2 0.0002
382 SCOLIOSIS 1 0.0002
383 CHOLANGITIS 1 0.0002
384 DYSARTHRIA 6 0.0002
385 SWELLING OF EYELID 1 0.0002
386 MULTIPLE INJURIES 1 0.0002
387 PHOTOPSIA 1 0.0002
388 ROTATOR CUFF SYNDROME 2 0.0002
389 HEPATITIS ACUTE 1 0.0002
390 RESPIRATORY TRACT INFECTION 4 0.0002
391 POLYP 1 0.0002
392 SPEECH DISORDER 8 0.0002
393 TOOTH INFECTION 2 0.0002
394 WALKING AID USER 1 0.0002
395 CYTOKINE RELEASE SYNDROME 3 0.0001
396 BREAST MASS 1 0.0001
397 WRONG PRODUCT ADMINISTERED 1 0.0001
398 PRODUCT LABEL ISSUE 1 0.0001
399 BLOOD TESTOSTERONE DECREASED 1 0.0001
400 ONYCHOCLASIS 1 0.0001
401 RESPIRATION ABNORMAL 1 0.0001
402 HAIR GROWTH ABNORMAL 1 0.0001
403 DELIRIUM 5 0.0001
404 MEDICATION ERROR 8 0.0001
405 EXTRASYSTOLES 1 0.0001
406 DEFAECATION URGENCY 1 0.0001
407 HEART RATE DECREASED 5 0.0001
408 OXYGEN SATURATION DECREASED 8 0.0001
409 SEASONAL ALLERGY 2 0.0001
410 DRY EYE 7 0.0001
411 FEAR OF INJECTION 1 0.0001
412 GRAFT VERSUS HOST DISEASE 1 0.0001
413 VISUAL FIELD DEFECT 1 0.0001
414 RASH PUSTULAR 1 0.0001
415 LIQUID PRODUCT PHYSICAL ISSUE 1 0.0001
416 ACCIDENTAL OVERDOSE 5 0.0001
417 BLOOD PRESSURE DIASTOLIC DECREASED 1 0.0001
418 CEREBRAL DISORDER 1 0.0001
419 DRUG DISPENSING ERROR 2 0.0001
420 INSURANCE ISSUE 2 0.0001
421 BOWEL MOVEMENT IRREGULARITY 1 0.0001
422 ANKLE FRACTURE 2 0.0001
423 LOW DENSITY LIPOPROTEIN INCREASED 1 0.0001
424 NERVOUS SYSTEM DISORDER 4 0.0001
425 PRODUCT ADMINISTRATION INTERRUPTED 1 0.0001
426 FURUNCLE 1 0.0001
427 PNEUMOTHORAX 2 0.0001
428 SENSORY DISTURBANCE 2 0.0001
429 OBSESSIVE-COMPULSIVE DISORDER 1 0.0001
430 MIOSIS 1 0.0001
431 RHINITIS 1 0.0001
432 MYASTHENIA GRAVIS 1 0.0001
433 POST PROCEDURAL INFECTION 1 0.0001
434 PHOTOSENSITIVITY REACTION 2 0.0001
435 GENERALISED TONIC-CLONIC SEIZURE 2 0.0001
436 HEMIPLEGIA 1 0.0001
437 URINARY RETENTION 4 0.0001
438 HALLUCINATION 9 0.0001
439 FACE OEDEMA 2 0.0001
440 HEMIPARESIS 2 0.0001
441 UNRESPONSIVE TO STIMULI 3 0.0001
442 ORTHOSTATIC HYPOTENSION 2 0.0001
443 NAIL DISORDER 1 0.0001
444 TUMOUR LYSIS SYNDROME 1 0.0001
445 ANGIOEDEMA 5 0.0001
446 PURPURA 1 0.0001
447 THIRST 2 0.0001
448 SYNCOPE 11 0.0001
449 BONE DISORDER 2 0.0001
450 PNEUMONIA BACTERIAL 1 0.0001
451 UROSEPSIS 1 0.0001
452 INTERVERTEBRAL DISC DEGENERATION 1 0.0001
453 APPENDICITIS 1 0.0001
454 HEPATIC CIRRHOSIS 2 0.0001
455 ARTERIOSCLEROSIS 1 0.0001
456 SPUTUM DISCOLOURED 1 0.0001
457 ABDOMINAL DISTENSION 11 0.0001
458 BLOOD PRESSURE DECREASED 7 0.0001
459 GASTRIC ULCER 2 0.0001
460 BALANCE DISORDER 9 0.0001
461 HYPERCHOLESTEROLAEMIA 1 0.0001
462 PRESCRIBED OVERDOSE 2 0.0001
463 RENAL TUBULAR NECROSIS 1 0.0001
464 HEPATOMEGALY 1 0.0001
465 PSYCHOTIC DISORDER 3 0.0001
466 ABNORMAL BEHAVIOUR 4 0.0001
467 HYPOTONIA 1 0.0001
468 EYELID PTOSIS 1 0.0001
469 DRY THROAT 1 0.0001
470 TOOTH ABSCESS 1 0.0001
471 BODY TEMPERATURE INCREASED 2 0.0001
472 THERAPY INTERRUPTED 7 0.0001
473 TEMPERATURE INTOLERANCE 1 0.0001
474 POOR VENOUS ACCESS 1 0.0001
475 PETECHIAE 1 0.0001
476 DRUG ADMINISTERED AT INAPPROPRIATE SITE 1 0.0001
477 SUDDEN DEATH 1 0.0001
478 BODY HEIGHT DECREASED 1 0.0001
479 MOVEMENT DISORDER 3 0.0001
480 BREAST CANCER METASTATIC 1 0.0001
481 NIGHT SWEATS 3 0.0001
482 CONFUSIONAL STATE 15 0.0001
483 PHARYNGITIS STREPTOCOCCAL 1 0.0001
484 ALTERED STATE OF CONSCIOUSNESS 2 0.0001
485 SWELLING FACE 6 0.0001
486 SKIN LACERATION 1 0.0001
487 PULMONARY THROMBOSIS 1 0.0001
488 IMPAIRED HEALING 3 0.0001
489 BLOOD GLUCOSE FLUCTUATION 1 0.0001
490 BACK PAIN 21 0.0001
491 VIRAL INFECTION 3 0.0001
492 VENTRICULAR FIBRILLATION 1 0.0001
493 HYPERTENSIVE CRISIS 1 0.0001
494 FISTULA 1 0.0001
495 CONSTIPATION 19 0.0001
496 METASTASES TO LUNG 1 0.0001
497 ELECTROLYTE IMBALANCE 1 0.0001
498 LOSS OF CONSCIOUSNESS 11 0.0001
499 SPLENOMEGALY 1 0.0001
500 HYPOXIA 3 0.0001
501 LYMPHADENOPATHY 3 0.0001
502 WHEEZING 5 0.0001
503 DIZZINESS 42 0.0001
504 PRODUCT PRESCRIBING ERROR 2 0.0001
505 NOCTURIA 1 0.0001
506 VERTIGO 5 0.0001
507 DYSURIA 3 0.0001
508 CARDIOMEGALY 1 0.0001
509 OSTEONECROSIS OF JAW 2 0.0001
510 HAIR COLOUR CHANGES 1 0.0001
511 INTENTIONAL PRODUCT USE ISSUE 7 0.0001
512 HEADACHE 50 0.0001
513 BRAIN OEDEMA 1 0.0001
514 COLITIS 3 0.0001
515 TACHYCARDIA 7 0.0001
516 CARDIOVASCULAR DISORDER 2 0.0001
517 SEIZURE 9 0.0001
518 DRUG RESISTANCE 2 0.0001
519 ERYTHEMA 16 0.0001
520 INFUSION SITE PAIN 1 0.0001
521 HAEMATOMA 2 0.0001
522 ALOPECIA 15 0.0001
523 SEDATION 2 0.0001
524 ORAL CANDIDIASIS 1 0.0001
525 INFUSION RELATED REACTION 5 0.0001
526 JOINT RANGE OF MOTION DECREASED 1 0.0001
527 DISTURBANCE IN ATTENTION 4 0.0001
528 DYSKINESIA 3 0.0001
529 LIMB INJURY 2 0.0001
530 CORONARY ARTERY OCCLUSION 1 0.0001
531 DRUG INTOLERANCE 7 0.0001
532 ANAPHYLACTIC REACTION 4 0.0001
533 SINUS TACHYCARDIA 1 0.0001
534 CONVULSION 4 0.0001
535 HYPERSOMNIA 2 0.0001
536 APATHY 1 0.0001
537 DYSSTASIA 2 0.0001
538 DRUG WITHDRAWAL SYNDROME NEONATAL 1 0.0001
539 URINARY INCONTINENCE 2 0.0001
540 PULMONARY MASS 1 0.0001
541 THERAPY NON-RESPONDER 3 0.0001
542 HYPOAESTHESIA ORAL 1 0.0001
543 TREMOR 11 0.0001
544 PRODUCT QUALITY ISSUE 9 0.0001
545 APHASIA 2 0.0001
546 BLOOD COUNT ABNORMAL 1 0.0001
547 EPILEPSY 2 0.0001
548 THYROID DISORDER 1 0.0001
549 WEIGHT DECREASED 18 0.0001
550 THERAPY PARTIAL RESPONDER 1 0.0001
551 BASAL CELL CARCINOMA 1 0.0001
552 HALLUCINATION, AUDITORY 1 0.0001
553 ANAEMIA 12 0.0001
554 ULCER 1 0.0001
555 MUSCLE TIGHTNESS 1 0.0001
556 DRY MOUTH 5 0.0001
557 BLOOD POTASSIUM INCREASED 1 0.0001
558 AMNESIA 4 0.0001
559 CHOLELITHIASIS 2 0.0001
560 VENTRICULAR TACHYCARDIA 1 0.0001
561 PSYCHOMOTOR HYPERACTIVITY 1 0.0001
562 HYPOAESTHESIA 9 0.0001
563 CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR 2 0.0001
564 FLUSHING 6 0.0001
565 SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION 1 0.0001
566 CHEST DISCOMFORT 6 0.0001
567 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 1 0.0001
568 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 3 0.0001
569 BURNING SENSATION 4 0.0001
570 AMENORRHOEA 1 0.0001
571 METASTASES TO LIVER 1 0.0001
572 COLD SWEAT 1 0.0001
573 DRUG INTERACTION 9 0.0001
574 BLOOD TRIGLYCERIDES INCREASED 1 0.0001
575 PRODUCT USE IN UNAPPROVED INDICATION 14 0.0001
576 ISCHAEMIC STROKE 1 0.0001
577 GASTROENTERITIS VIRAL 1 0.0001
578 LEUKOCYTOSIS 1 0.0001
579 TOOTHACHE 1 0.0001
580 OSTEOMYELITIS 1 0.0001
581 RESPIRATORY FAILURE 4 0.0001
582 HYPOTENSION 11 0.0001
583 END STAGE RENAL DISEASE 1 0.0001
584 SOMNOLENCE 11 0.0001
585 AGITATION 4 0.0001
586 INJECTION SITE MASS 2 0.0001
587 BRONCHITIS 4 0.0001
588 HYPERSENSITIVITY 10 0.0001
589 TUBULOINTERSTITIAL NEPHRITIS 1 0.0001
590 BLOOD SODIUM DECREASED 1 0.0001
591 BLOOD URINE PRESENT 1 0.0001
592 SLEEP APNOEA SYNDROME 1 0.0001
593 HERPES ZOSTER 3 0.0001
594 LETHARGY 3 0.0001
595 HYPERTENSION 11 0.0001
596 EAR PAIN 1 0.0001
597 BLOOD PRESSURE SYSTOLIC INCREASED 1 0.0001
598 BONE PAIN 3 0.0001
599 NASAL CONGESTION 3 0.0001
600 KIDNEY INFECTION 1 0.0001
601 DISABILITY 1 0.0001
602 DEPRESSED LEVEL OF CONSCIOUSNESS 2 0.0001
603 HAEMATOCRIT DECREASED 1 0.0001
604 COMPLICATION OF DEVICE INSERTION 1 0.0001
605 CONDITION AGGRAVATED 15 0.0000
606 TASTE DISORDER 1 0.0000
607 FEELING HOT 3 0.0000
608 SINUSITIS 5 0.0000
609 INJECTION SITE WARMTH 1 0.0000
610 RIB FRACTURE 1 0.0000
611 POLLAKIURIA 2 0.0000
612 DERMATITIS 1 0.0000
613 DYSPNOEA 27 0.0000
614 RENAL FAILURE ACUTE 2 0.0000
615 GAIT DISTURBANCE 9 0.0000
616 EATING DISORDER 1 0.0000
617 JOINT INJURY 1 0.0000
618 NAUSEA 37 0.0000
619 POOR QUALITY SLEEP 1 0.0000
620 SKIN CANCER 1 0.0000
621 PRURITUS GENERALISED 1 0.0000
622 INCORRECT PRODUCT ADMINISTRATION DURATION 1 0.0000
623 SEPTIC SHOCK 2 0.0000
624 MENTAL DISORDER 2 0.0000
625 INTERVERTEBRAL DISC PROTRUSION 1 0.0000
626 OFF LABEL USE 40 0.0000
627 RASH MACULO-PAPULAR 1 0.0000
628 INFLUENZA 5 0.0000
629 VOMITING 21 0.0000
630 THROAT IRRITATION 2 0.0000
631 CHROMATURIA 1 0.0000
632 HEART RATE IRREGULAR 1 0.0000
633 PRODUCT AVAILABILITY ISSUE 1 0.0000
634 MUSCLE SPASMS 8 0.0000
635 MUSCLE TWITCHING 1 0.0000
636 DIARRHOEA 28 0.0000
637 HYPOKALAEMIA 2 0.0000
638 UPPER RESPIRATORY TRACT INFECTION 2 0.0000
639 PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME 1 0.0000
640 INJURY 3 0.0000
641 SLEEP DISORDER 3 0.0000
642 MIGRAINE 4 0.0000
643 URTICARIA 7 0.0000
644 DIABETIC KETOACIDOSIS 1 0.0000
645 FIBROMYALGIA 1 0.0000
646 NEURALGIA 1 0.0000
647 ENCEPHALOPATHY 1 0.0000
648 PYREXIA 14 0.0000
649 PNEUMONIA ASPIRATION 1 0.0000
650 ACNE 3 0.0000
651 CHRONIC KIDNEY DISEASE 3 0.0000
652 BLOOD PRESSURE INCREASED 6 0.0000
653 HEPATITIS 1 0.0000
654 THERAPY CESSATION 2 0.0000
655 ERECTILE DYSFUNCTION 1 0.0000
656 RASH GENERALISED 1 0.0000
657 PHARMACEUTICAL PRODUCT COMPLAINT 1 0.0000
658 PSORIASIS 5 0.0000
659 MUCOSAL INFLAMMATION 1 0.0000
660 MUSCULOSKELETAL PAIN 2 0.0000
661 PARAESTHESIA 6 0.0000
662 ANHEDONIA 1 0.0000
663 RENAL FAILURE 5 0.0000
664 FEELING ABNORMAL 9 0.0000
665 DRUG EFFECT DECREASED 2 0.0000
666 THROAT TIGHTNESS 1 0.0000
667 PALLOR 1 0.0000
668 PNEUMONITIS 1 0.0000
669 RASH 16 0.0000
670 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 2 0.0000
671 RESPIRATORY ARREST 1 0.0000
672 RESPIRATORY DISTRESS 1 0.0000
673 DRUG ABUSE 3 0.0000
674 FATIGUE 28 0.0000
675 BLISTER 2 0.0000
676 PRODUCT DOSE OMISSION IN ERROR 1 0.0000
677 FLATULENCE 2 0.0000
678 ANXIETY 10 0.0000
679 INTENTIONAL DOSE OMISSION 1 0.0000
680 GENERAL PHYSICAL HEALTH DETERIORATION 4 0.0000
681 INTENTIONAL PRODUCT MISUSE 3 0.0000
682 CHILLS 4 0.0000
683 RENAL INJURY 1 0.0000
684 RESPIRATORY DISORDER 1 0.0000
685 ADVERSE DRUG REACTION 3 0.0000
686 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 6 0.0000
687 DISCOMFORT 2 0.0000
688 ACUTE KIDNEY INJURY 5 0.0000
689 DRUG ADMINISTRATION ERROR 1 0.0000
690 LIMB DISCOMFORT 1 0.0000
691 FEMUR FRACTURE 1 0.0000
692 DRUG-INDUCED LIVER INJURY 1 0.0000
693 HEAD INJURY 1 0.0000
694 CYSTITIS 1 0.0000
695 HYPOTHYROIDISM 1 0.0000
696 PRODUCT DOSE OMISSION 2 0.0000
697 PRODUCT DOSE OMISSION ISSUE 9 0.0000
698 OSTEONECROSIS 1 0.0000
699 THERAPEUTIC RESPONSE SHORTENED 1 0.0000
700 FUNGAL INFECTION 1 0.0000
701 GAIT INABILITY 1 0.0000
702 TYPE 2 DIABETES MELLITUS 1 0.0000
703 TRANSIENT ISCHAEMIC ATTACK 1 0.0000
704 ANGER 1 0.0000
705 HAEMATURIA 1 0.0000
706 RASH MACULAR 1 0.0000
707 COVID-19 5 0.0000
708 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 2 0.0000
709 INCORRECT ROUTE OF DRUG ADMINISTRATION 1 0.0000
710 CEREBRAL HAEMORRHAGE 1 0.0000
711 HYPERGLYCAEMIA 1 0.0000
712 PANIC ATTACK 1 0.0000
713 SEPSIS 3 0.0000
714 ABDOMINAL PAIN 6 0.0000
715 PALPITATIONS 3 0.0000
716 INJECTION SITE HAEMORRHAGE 2 0.0000
717 CARDIAC FAILURE 2 0.0000
718 GASTROOESOPHAGEAL REFLUX DISEASE 2 0.0000
719 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 5 0.0000
720 NEUTROPHIL COUNT DECREASED 1 0.0000
721 ARTHRALGIA 10 0.0000
722 CARDIO-RESPIRATORY ARREST 1 0.0000
723 ROAD TRAFFIC ACCIDENT 1 0.0000
724 ABDOMINAL DISCOMFORT 4 0.0000
725 OSTEOARTHRITIS 1 0.0000
726 URINARY TRACT INFECTION 4 0.0000
727 OVERDOSE 5 0.0000
728 PAIN 14 0.0000
729 COLITIS ULCERATIVE 1 0.0000
730 DEPRESSION 5 0.0000
731 MEMORY IMPAIRMENT 3 0.0000
732 TINNITUS 1 0.0000
733 BLOOD CHOLESTEROL INCREASED 1 0.0000
734 COGNITIVE DISORDER 1 0.0000
735 COUGH 6 0.0000
736 SWELLING 2 0.0000
737 PRODUCT USE ISSUE 4 0.0000
738 ASTHENIA 8 0.0000
739 BLOOD GLUCOSE INCREASED 4 0.0000
740 DYSPHAGIA 2 0.0000
741 NEUROPATHY PERIPHERAL 2 0.0000
742 DISEASE RECURRENCE 1 0.0000
743 PRODUCTIVE COUGH 1 0.0000
744 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 1 0.0000
745 HYPOGLYCAEMIA 1 0.0000
746 ATRIAL FIBRILLATION 2 0.0000
747 DRUG INEFFECTIVE 27 0.0000
748 DYSPEPSIA 2 0.0000
749 HEART RATE INCREASED 2 0.0000
750 AGGRESSION 1 0.0000
751 CELLULITIS 1 0.0000
752 FLUID RETENTION 1 0.0000
753 MALIGNANT NEOPLASM PROGRESSION 2 0.0000
754 HAEMOGLOBIN DECREASED 2 0.0000
755 ILLNESS 2 0.0000
756 DERMATITIS ATOPIC 1 0.0000
757 DEPRESSED MOOD 1 0.0000
758 ASPARTATE AMINOTRANSFERASE INCREASED 1 0.0000
759 DRUG DEPENDENCE 3 0.0000
760 OEDEMA 1 0.0000
761 TREATMENT NONCOMPLIANCE 1 0.0000
762 ARTHROPATHY 1 0.0000
763 PANCYTOPENIA 1 0.0000
764 THROMBOCYTOPENIA 2 0.0000
765 CEREBROVASCULAR ACCIDENT 3 0.0000
766 MUSCULAR WEAKNESS 2 0.0000
767 INCORRECT DOSE ADMINISTERED 4 0.0000
768 DYSPHONIA 1 0.0000
769 BLADDER CANCER 1 0.0000
770 IRRITABILITY 1 0.0000
771 ILL-DEFINED DISORDER 1 0.0000
772 OEDEMA PERIPHERAL 2 0.0000
773 ALANINE AMINOTRANSFERASE INCREASED 1 0.0000
774 CHEST PAIN 3 0.0000
775 BLOOD CREATININE INCREASED 1 0.0000
776 DEVICE DIFFICULT TO USE 1 0.0000
777 FEBRILE NEUTROPENIA 1 0.0000
778 DRY SKIN 2 0.0000
779 NEUTROPENIA 2 0.0000
780 HEPATIC ENZYME INCREASED 1 0.0000
781 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 1 0.0000
782 MOBILITY DECREASED 1 0.0000
783 DYSGEUSIA 1 0.0000
784 EPISTAXIS 1 0.0000
785 HOT FLUSH 1 0.0000
786 DIABETES MELLITUS 1 0.0000
787 INJECTION SITE PAIN 4 0.0000
788 HOSPITALISATION 2 0.0000
789 PRURITUS 5 0.0000
790 ARTHRITIS 1 0.0000
791 INJECTION SITE BRUISING 1 0.0000
792 CARDIAC FAILURE CONGESTIVE 1 0.0000
793 PNEUMONIA 4 0.0000
794 FOETAL EXPOSURE DURING PREGNANCY 1 0.0000
795 FALL 4 0.0000
796 RENAL IMPAIRMENT 1 0.0000
797 PRODUCT STORAGE ERROR 1 0.0000
798 MALAISE 5 0.0000
799 DRUG WITHDRAWAL SYNDROME 1 0.0000
800 INSOMNIA 3 0.0000
801 MATERNAL EXPOSURE DURING PREGNANCY 1 0.0000
802 GASTROINTESTINAL DISORDER 1 0.0000
803 NO ADVERSE EVENT 2 0.0000
804 BREAST CANCER 1 0.0000
805 CARDIAC DISORDER 1 0.0000
806 PULMONARY EMBOLISM 1 0.0000
807 CONTUSION 1 0.0000
808 PAIN IN EXTREMITY 3 0.0000
809 HAEMORRHAGE 1 0.0000
810 PLATELET COUNT DECREASED 1 0.0000
811 WHITE BLOOD CELL COUNT DECREASED 1 0.0000
812 ASTHMA 1 0.0000
813 RHEUMATOID ARTHRITIS 1 0.0000
814 DECREASED APPETITE 2 0.0000
815 DISEASE PROGRESSION 1 0.0000
816 JOINT SWELLING 1 0.0000
817 EMOTIONAL DISTRESS 1 0.0000
818 INJECTION SITE ERYTHEMA 1 0.0000
819 HYPERHIDROSIS 1 0.0000
820 DEHYDRATION 1 0.0000
821 TOXICITY TO VARIOUS AGENTS 1 0.0000
822 MYALGIA 1 0.0000
823 MYOCARDIAL INFARCTION 1 0.0000
824 NASOPHARYNGITIS 1 0.0000
825 ABDOMINAL PAIN UPPER 1 0.0000
826 WEIGHT INCREASED 1 0.0000
827 DEATH 3 0.0000